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Tuesday, March 8, 2011 453afatal arrhythmia and ventricular ischemia due to the restricted ventricles and
enlarged atria. The transgenic mouse model provides us with a good tool to
study the mechanisms and the cause of the death of RCM, which will be useful
for the prevention and treatment of the disease.
2456-Pos Board B442
Both PKA Treatment and Cardiac Troponin-I N-Terminal Phosphoryla-
tion Alone Decrease Ca-Sensitivity and Eliminate Length-Dependent
Activation in Skinned Cardiac Muscle
Donald A. Martyn, Steven Korte, Maria Razumova, Erik Feest,
Thomas Irving, Michael Regnier.
Protein kinase A (PKA) phosphorylation of myofibrillar proteins constitutes an
important pathway forb-adrenergicmodulation of cardiac contractility. PKA tar-
gets the cardiac troponin I (cTnI) N-terminus, cardiac myosin-binding protein C
(cMyBP-C) and titin. To isolate cTnI and cMyBP-C /titin phosphorylation effects
on force-[Ca2þ] relations, endogenous cardiac troponin (Tn) was exchanged in
rat, skinned trabeculae with either WT Tn or Tn containing a non-
phosphorylatable mutant cTnI(S23/24A) or phosphomimetic cTnI(S23/24D).
PKA cannot phosphorylate either cTnI mutant, leaving cMyBP-C and titin as
sole PKA targets. Force-[Ca2þ] relations andCa2þ-sensitivity (pCa50)weremea-
sured at 2.3 and 2.0mmSL.Decreasing steady SL reducedmaximal force (Fmax)
and pCa50 similarly with WT Tn and Tn containing cTnI(S23/24A). PKA treat-
ment of native, WT and cTnI(S23/24A) exchanged trabeculae reduced pCa50 at
2.3, but not 2.0 umSL, eliminatingSL-dependence of pCa50.Reconstitutionwith
Tn containing cTnI(S23/24D) reduced pCa50 at both SL (compared to WT and
cTnI(S23,24A) and eliminated pCa50 SL-dependence; PKA did not significantly
alter pCa50 at either SL. At each SL Fmax was similar with WT and mutant tro-
ponins, and was unaffected by PKA. Low angle x-ray diffraction experiments
were performed to determine whether shifts in pCa50 were associated with
changes inmyofilament spacing (D1,0) or interaction.D1,0 at 2.3 umSLwas sim-
ilar in native trabeculae, withWT Tn and Tn containing either cTnI(S23,24A) or
cTnI(S23,24D); PKA increased D1,0 in all cases. The results suggest that PKA
phosphorylation of either cTnI or cMyBP-C /titin reduced the Ca2þ-sensitivity
of force and length-dependent activation. Supported by NIH HL067071-06.
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Reducing Thin Filament Ca2þ Affinity with a cTnC Variant (L57Q) Re-
duces Force but Enhances Cross-Bridge Dependence of Cooperative
Activation in Demembranated Rat Trabeculae
Cameron W. Turtle, Frederick S. Korte, Maria V. Razumova,
Michael Regnier.
Activation of cardiac contraction is initiated by binding of Ca2þ to troponin C
(cTnC) and regulated by cooperative strong cross-bridge binding. We previ-
ously showed that passive exchange with cTn containing a cTnC variant,
L48Q, increased Ca2þ sensitivity of force development and eliminated sarco-
mere length (SL) dependence of Ca2þ sensitivity of force in rat cardiac trabec-
ulae. This was shown to be due to decreased reliance on strong cross-bridge
binding for full thin-filament activation, possibly due to stronger cTnC-cTnI in-
teraction. We also showed that PKA phosphorylation decreased Ca2þ sensitiv-
ity of force and eliminated SL dependence of force-pCa relations, by unknown
specific mechanisms. Here we test the hypothesis that incorporation of a cTnC
variant with decreased Ca2þ binding affinity, L57Q cTnC, will result in in-
creased reliance on cross-bridge binding for full activation, thus increasing
SL-dependence of Ca2þ sensitivity. As expected, results indicate trabeculae
passively exchanged with L57Q cTnC-cTn displayed decreased Ca2þ sensitiv-
ity and rate of force production compared to WT cTnC at a given [Ca2þ]. In-
terestingly, preliminary results indicate L57Q cTnC-cTn mildly increased the
SL-dependence of Ca2þ sensitivity of force and also significantly decreased
maximal force. Both of these effects were not observed in PKA-treated trabec-
ulae, which had a comparable reduction in Ca2þ sensitivity of force. These
findings suggest that reducing cTnC Ca2þ affinity per se can reduce Ca2þ sen-
sitivity of contractile activation to the point of limited overall force production,
which may enhance cross-bridge dependence of cooperative thin filament acti-
vation. Current experiments aim to increase force in L57Q cTnC (to near WT
cTnC) by increasing cross-bridge attachment using 2’-deoxy-ATP, which has
previously been shown to increase force and Ca2þ sensitivity while maintain-
ing SL dependence. NIH-HL65497(MR), AHA-2310117(FSK).
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Fluorescence Measurements Using Rhodamine-Labeled cTnCMutants In-
dicate Little Cooperative Interaction Between Cardiac Thin Filament
Regulatory Units
Don Martyn, Vijay Rao, Michael Regnier.
Exchange of mixtures of WT cTnC and mutant cTnC(D65A), which cannot
bind Ca2þ at N-terminal site II (‘‘dead’’ cTnC), reduced maximal Ca2þ acti-
vated force (Fmax) with little effect on force-Ca2þ relations and force kineticsin skinned cardiac trabeculae (Gillis et al., J Physiol. 580:561-76, 2007), sug-
gesting interaction between structural regulatory units (RUs; 7 actins, 1 tropo-
nin, 1 tropomyosin) along cardiac thin filaments is less than in skeletal muscle
(Regnier et al., J Physiol. 540:485-97, 2002). To more directly test that this
finding, we exchanged skinned cardiac trabeculae with mixtures of mutant
cTnC(C35S) and cTnC(C35S,D65A), with one or the other labeled at Cys 84
with 5’tetramethyl rhodamine (IATR) for dichroism measurements. In trabec-
ulae exchanged with 100% cTnC(C35S)-IATR, dichroism increased in re-
sponse to both Ca2þ and rigor crossbridges, while trabeculae with 100% Tn
containing (cTnC(C35S,D65A)-IATR) had no response to Ca2þ, but retained
a strong response to rigor crossbridge binding. This response to strong cross-
bridges allows use of cTnC(C35S,D65A)-IATR to determine if isolated regu-
latory units containing cTnC(C35S,D65A)-IATR are perturbed by Ca2þ-
induced active contraction in adjacent ‘‘live’’ RUs. To test this, trabeculae
were exchanged with a mixture of 20% functional cTnC(C35S)-IATR and
80% unlabeled cTnC(C35S,D65A), to isolate functional RUs. Fmax decreased
but there was little change in the Ca2þ-dependence of dichroism compared to
trabeculae exchanged with 100% functional cTnC(C35S)-IATR. These data in-
dicate minimal or no apparent spread of activation between adjacent RUs in
cardiac muscle, indicating that the apparent cooperativity of force production
in cardiac muscle results from interactions between myosin and thin filaments
within a thin filament structural regulatory unit. Supported by NIH RO1-
HL65497 (Regnier).
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Combination of Phosphomimetic Substitutions within Cardiac Troponin I
Cause Functional Cross-Talk
Sarah E. Kampert, Tamara K. Stevenson, Mark A. Jensen, Erin M. Keyes,
Gail L. Romanchuk, Margaret V. Westfall.
Protein kinase C (PKC) phosphorylates 3 clusters of residues within cardiac tro-
ponin I (cTnI) andyet, it is unclearwhether phosphorylation atmultiple sites pro-
duces additive and/or divergent functional modifications. Our goal was to
evaluate the influence of cTnI with phosphomimetic substitutions on contractile
performance under basal conditions and in response to PKC activation by endo-
thelin. Endogenous cTnI was replaced with phosphomimetic substitutions using
adenoviral-mediated gene transfer into adult rat cardiac myocytes. Phosphomi-
metics of Ser43/45, Ser43/45 plus Thr144, and Ser23/24 plus Ser43/45 were
substituted with Asp to form AdcTnISer43/45Asp, cTnIAspTriple (e.g.
cTnISer43/45AspThrT144Asp), and cTnIAspQuad (cTnISer23/24/43/45Asp).
Isolatedmyocytes were electronically paced and studied 4 days after gene trans-
fer. Gene transfer of epitope-tagged versions of each construct resulted in 30-
40% replacement after 2 days and >65% replacement of endogenous cTnI 4
days after gene transfer without significant alterations in the expression of other
myofilament proteins. In functional studies, peak shortening amplitude was sig-
nificantly decreased in myocytes expressing cTnISer43/45Asp or cTnIAspQuad,
while peak shortening in myocytes expressing cTnIAspTriple was not signifi-
cantly different from controls. Relaxation was accelerated in myocytes express-
ing cTnIAspQuad, but was not different from controls in myocytes expressing
cTnIAspTriple or cTnISer43/45Asp. Together, these results suggest the Ser23/
24 and Ser43/45 sites have an additive influence on shortening, while substitu-
tion at Thr144 attenuates the influence of Ser43/45 on peak shortening. To fur-
ther determine whether multiple phosphomimetic substitutions within cTnI
influence myocyte shortening, we studied the change in peak shortening and re-
laxation produced by the PKC agonist, endothelin (10 nM). In preliminary stud-
ies, the increased peak amplitude and accelerated relaxation observed in control
myocytes is not significantly different in myocytes expressing cTnISer43/
45Asp. However, there is a trend for myocytes expressing cTnIAspQuad to
show an attenuated amplitude and relaxation response to ET.
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The Motif of Myosin Binding Protein-C is Mechanically Weak and
Extensible
Arpad Karsai, Samantha P. Harris, Miklo´s Kellermayer.
Cardiac myosin binding protein-C (cMyBP-C) is a member of the immuno-
globulin (Ig) superfamily of proteins and consists of 8 Ig- and 3 fibronectin
(Fn)-like domains along with a unique regulatory sequence referred to as the
MyBP-C ‘‘motif’’ or M-domain. The structure of the M-domain is not known,
but small angle X-ray scattering experiments suggest that it adopts a compact
shape in solution and that its overall dimensions are similar to other Ig-like do-
mains. To investigate whether the M-domain behaves similarly to an Ig domain
under mechanical stress or load, we used atomic force microscopy (AFM) to
investigate single molecule elasticity and mechanical properties of recombinant
full-length mouse cardiac cMyBP-C and smaller proteins containing just the M-
domain and flanking Ig- sequences. Force-extension curves of full-length
cMyBP-C showed unfolding of individual Ig or Fn-like domains at forces
454a Tuesday, March 8, 2011between 40-150 pN (500 nm/s pulling speed) which were evident as ‘‘saw
tooth’’ peaks in force spectra. Spectra with up to 11 peaks were obtained.
The curves also revealed region(s) of very low stability that could be stretched
>100 nm prior to any unfolding event. In force extension curves of a shorter
three domain construct comprised only of the M-domain and its two flanking
Ig domains (i.e., C1-M-C2) an extensible region with a contour length of
435 4 nm and persistence length of 0.425 0.1 nm was also observed before
domain unfolding in no more than two sawtooth peaks. The latter data suggest
that the M-domain contributes to the extensible segment of cMyBP-C and that
the M-domain exhibits mechanical properties that are distinct from those of Ig
or Fn-like domains. The M-domain may thus function as a spring-like element
within cMyBP-C. Supported by NIH HL080367.
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N-Terminal Fragment of Cardiac Myosin Binding Protein-C (CMYBP-C)
Reduces Actomyosin Power Output in the Laser Trap Assay
Abbey Weith, James Gulick, Peter VanBuren, Jeffrey Robbins,
David M. Warshaw.
Mutations in cMyBP-C cause hypertrophic cardiomyopathy, but cMyBP-C’s
modulation of cardiac contractility is poorly understood. The N-terminus of
cMyBP-C binds actin and myosin S2, while the C-terminus binds the myosin
rod. Thus, cMyBP-C may act as a tether between the thick and thin filament,
imposing a load against which myosin must operate. We used a laser trap force
clamp assay (Debold et al. B.J., 2005) to characterize actomyosin’s force veloc-
ity relationship (F:V) in the absence and presence of a bacterially expressed N-
terminal cMyBP-C fragment, C0C3. In this assay a small ensemble of skeletal
myosin (~8 heads) translocates a skeletal actin filament under a series of con-
stant loads (1-8 pN), resulting in a classic hyperbolic F:V with a maximum iso-
metric force of 10 5 2 pN. Adding C0C3 at a 1:1 ratio to myosin depressed
actomyosin’s F:V: i.e. 48% reduction in maximum unloaded velocity with
no effect on maximum force. This reduced actomyosin’s maximum power out-
put by 40%. The depressed velocities suggest C0C3 may impose as much as 2
pN of opposing load to the myosin ensemble. As limited numbers of myosin
translocate the actin filament under load, a finite probability exists that no my-
osin will be attached, causing rapid (~2 ms duration) backward movements (34
5 1 nm) of the actin filament, i.e. slips. The frequency of slips rises with in-
creasing load, which is diminished significantly in the presence of C0C3, sug-
gesting C0C3 prevents slips by its attachment to the actin filament. Based on
the depression of the F:V and fewer actin filament slips in the presence of
C0C3, we propose that the N-terminus of cMyBP-C can tether actin and impose
an effective viscous load in the sarcomere to modulate cardiac power output.
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Charged Amino Acids in the N-Terminus of Cardiac Myosin Binding
Protein-C Contribute to Contractile Effects in Permeabilized Myocytes
Kristina L. Bezold, Samantha P. Harris.
Recombinant N-terminal domains of cardiac myosin binding protein C
(cMyBP-C) increase calcium-sensitivity of force (pCa50) and the rate of ten-
sion redevelopement (ktr) in permeabilized cardiac myocytes. To identify spe-
cific amino acids required for these effects, we investigated functional effects
of alanine substitution mutations of charged residues near phosphorylation sites
within the regulatory M-domain of cMyBP-C. Mutations were introduced into
a recombinant protein, C1C2, comprised of the M-domain and its two flanking
Ig domains (i.e, C1-M-C2). Compared to wild-type C1C2, a double mutant
containing A for R substitutions at positions 270 and 271 upstream of S273
(phosphorlyation site A), reduced the ability of C1C2 to increase force in per-
meabilized rat cardiac trabeculae. Another double mutant, the 299AA300 substi-
tution for 299KR300 upstream of S302 (phosphorylation site C), also reduced the
efficacy of C1C2. A triple mutant that replaced a cluster of three charged res-
idues 298KKR300 nearly abolished the functional effects of C1C2. These results
suggest that positively charged amino acids upstream of protein kinase A phos-
phorylation sites are important for mediating the contractile effects of C1C2
and that these sites may be involved in the in vivo response to -adrenergic stim-
ulation potentially by contributing to binding of the M-domain to actin and/or
myosin S2. This work is supported by NIH HL080367 to SPH and a DOD
NDSEG fellowship to KLB.
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Uncovering Effects of the Familial Hypertrophic Cardiomyopathy
(fHCM) Related ß-Myosin Mutation Arg723gly in Human Cardiomyo-
cytes
Theresia Kraft, Nicky M. Boontje, Snigdha Tripathi, Antonio Francino,
Francisco Navarro-Lo´pez, Bernhard Brenner, Ger J. Stienen, Jolanda van,
der Velden.
Mutations in sarcomeric proteins have been identified as the major cause of
fHCM. The primary functional effects of these mutations at the sarcomere levelof cardiomyocytes, however, are still largely unknown. To address this point
we studied cardiomyocytes of the left ventricle (LV) from explanted hearts
of two patients with ß-myosin (ß-MHC) mutation R723G (Enjuto et al.,
JMCC 2000).
Our measurements revealed reduced maximum force generation of myocytes
but unchanged calcium-sensitivity. In contrast, previous studies on slow skel-
etal muscle fibers expressing ß-MHC with the same mutation showed reduced
calcium-sensitivity and increased maximum force. To address this discrepancy
we first determined the expression of mutated and wildtype ß-MHC-mRNA in
LV tissue. 6252% of total ß-MHC-mRNA was found to contain the mutation,
just as seen in M. soleus. Secondly, similar to previous findings for failing hu-
man heart, gel electrophoresis of the fHCM cardiac tissue showed reduced
phosphorylation of troponins I (TnI) and T, myosin binding protein C
(MyBP-C), and myosin light chain 2 compared to donor tissue. Adjustment
of phosphorylation of TnI and MyBP-C in donor and HCM myocytes by treat-
ment with protein kinase A (PKA), however, uncovered an originally masked
reduction in calcium-sensitivity while maximum force was not affected by
PKA treatment. Electron microscopy showed reduced myofibrillar density in
cardiac tissue samples of the patients which may account for the reduced force.
In conclusion, our study reveals that secondary, adaptational processes, trig-
gered by the fHCM-related mutation, can obscure primary effects.
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Zipper-Interacting Protein Kinase Phosphorylates Cardiac Myosin
Audrey N. Chang, Guohua Chen, Pavan Battiprolu, Robert D. Gerard,
Cheng-Hai Zhang, Min-Sheng Zhu, Kristine E. Kamm, James T. Stull.
Zipper-interacting protein kinase (ZIPK) or DAPK3, is a member of the death-
associated-protein kinase family associated with apoptosis in nonmuscle cells
where it phosphorylates myosin regulatory light chain (RLC) to promote mem-
brane blebbing. ZIPK mRNA is abundant in muscles, prompting our investiga-
tion of its role in the heart. A substrate search on mouse heart homogenates led
to the discovery that cardiac RLC is a substrate for ZIPK. Enzyme kinetic stud-
ies revealed that both smooth and cardiac RLCs were good substrates, with
a Vmax value two-fold greater for cardiac as compared to smooth/nonmuscle
RLC. Moreover, ZIPK phosphorylated cardiac RLC at Ser15, the site respon-
sible for modulating Ca2þ sensitivity of myofibrillar contraction. Knockdown
of ZIPK in isolated neonatal cardiac myocytes by siRNA decreased the extent
of RLC Ser15 phosphorylation. Localization studies using adenovirus- medi-
ated overexpression of GFP-ZIPK in neonatal and adult rat cardiac myocytes
showed it is in the nucleus, but also the cytoplasm where it may affect RLC
phosphorylation. In adult cardiac myocytes, ZIPK appears to associate with
myofilaments. ZIPK gene ablation specifically in mouse heart (ZKflox/
Nkx2.5Cre) did not affect basal RLC phosphorylation, nor did it induce appar-
ent pathological responses (assessed by histological analysis and heart weight
measurements). Based on what is known about the DAPK family, we hypoth-
esize that ZIPK function in the heart may be stress or death signal-dependent.
Effects of physiological and pathophysiological stresses on hearts from ZKflox/
Nkx2.5Cre mice are currently being investigated. Supported by NIH NHLBI (J.
T. S.) and AHA Postdoctoral Fellowship (A.N.C.).
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Kinetics of Mouse Alpha-Myosin S1 a Fast Myosin
Heresh Rezavandi, Michael A. Geeves.
The fast skeletal muscle myosins and the slow/b-cardiac myosins have been
well described but few kinetic studies of the a cardiac myosin have been pre-
sented. Here we show that the mouse alpha cardiac myosin has more in com-
mon with fast skeletal type myosin than the slower B-type myosin. The data
for individual rate constant for mouse a myosin S1 are compared to our pub-
lished values for the rabbit fast muscle and slow/bmyosin S1. The ADP affinity
for acto.S1 is much weaker (250 mM) than beta-S1 (10 mM) and similar to that
of fast rabbit muscle S1 (120 mM). The rate constant for ADP release is too fast
to measure for mouse a -S1 and rabbit fast muscle S1 but 63 s1 for the rabbit
b-S1. For all myosins affinity of actin form myosin is reduced by ADP and the
affinity of ADP for S1 is reduced by actin. This thermodynamic coupling ratio
is 10 for b-S1 but ~50-100 for fast muscle S1 and a-S1. The ATP hydrolysis
step rate constant estimated from the protein fluorescence changes is 150 s1
similar tor fast muscle S1 (120 s1) and faster that b-S1 (21 s1). These values
suggest that the ADP release from AMD and the hyrdolysis step are changed in
parallel and this is consistent with the hydrolysis step having a role in defining
the lifetime of the detached state (M.ATP) while ADP release controls the
lifetime of the attached state. Thus the duty ratio can remain similar while
the cycle time is altered. All other values assayed show no major difference be-
tween the three isoforms of myosin. Overall despite the greater sequence sim-
ilarity between a and b cardic S1 the a-S1 shares kinetic properties with the fast
muscle S1.
